Antimicrobial Agents and Resistance

Antimicrobial Agents and Resistance (AAR) will cover a range of important topics. One of the major challenges today is the rising tide of antimicrobial resistance, with the emergence of "untreatable" microbes causing diseases that were once readily treatable. The AAR track is the best place to find information regarding new antimicrobial agent discovery, preclinical investigations of new antimicrobial drugs in the pipeline, and first-look data of human clinical trials using new antimicrobial agents. 

Antimicrobial Agents and Resistance includes

  • Surveillance of Antimicrobial Resistance: Molecular Typing, Clinical and Molecular Epidemiology
  • Antimicrobial Agents: Mechanisms of Action and Mechanisms of Resistance
  • Antifungal Agents and Resistance
  • Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology
  • Antimicrobial Stewardship, including Quality of Care 
  • Antiviral Agents (including HIV Drugs) and Resistance
  • Experimental Therapeutics
  • New Antimicrobial Agents (Pre-US IND or Prior to the Start of Clinical Therapeutic Studies/pre-Phase 2) and New Research Technologies
  • Pharmacological Studies of Antimicrobial Agents Pre-NDA (Phase 2/3)

    Related Conference of Antimicrobial Agents and Resistance

    Antimicrobial Agents and Resistance Conference Speakers